Professor Tzu-Ming Pan and SunWay Biotech were triple awarded National Innovation Award Excelsior Award!
- Author: sunway
- Category: Company News
With the continuous innovation and advancements in R&D, the project “Study on Application of Red Mold Rice- Improvement of Memory and Learning Abilities of Alzheimer’s Patient and Metabolic Symptom”, researched by Professor Tzu-Ming Pan and SunWay Biotech research team, was triple awarded National Innovation Award Excelsior Award on 23 Dec 2022!
For more information: https://reurl.cc/ROAejr
Related posts
The product, Red Yeast Rice, nominated by SunWay Biotech and our clients XYMOGEN, has been recognized as Finalist at NutraIngredients USA Awards 2022: Botanical Product of the Year.
Exciting News! The product, Red Yeast Rice, nominated by SunWay Biotech and our clients XYMOGEN, has been recognized as Finalist at NutraIngredients USA Awards 2022: Botanical Product of the Year. https://reurl.cc/j1rOg1 Thanks to all the judges for recognizing our team’s effort in developing stain-free Red Yeast Rice. If you want to learn more about the statin-free red yeast rice extract, ANKASCIN 568-R, check out our website: https://reurl.cc/rDYkkx #botanical #sunway #xymogen #NutraIngredients #ankascin 568-r
- Author: sunway
- Category: Company News
Congratulations! The innovation of Professor Tzu-Ming Pan and SunWay Biotech is awarded “Advanced National Innovation Award” on 1 Dec 2020!
We, Innovators The innovation of Professor Tzu-Ming Pan and SunWay Biotech “The Red Yeast Rice- Improvement of Memory and Learning Abilities of Alzheimer’s Patients” was awarded the National Innovation Award in 2008. With the continuous innovation, specific research, and development process for promotion worldwide, this application has been twice awarded the “Advanced National Innovation Award” on 1 Dec 2020! Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award
- Author: sunway
- Category: Company News
Vigiis® 101-LAB probiotic shows benefits to improve gut microflora.
The first clinical study, which has been published in Heliyon, documents that Vigiis® 101-LAB significantly increases the bacterial counts of Bifidobacterium spp. and Lactobacillus spp. in feces in just one week, and maintains those elevated counts for four weeks. Thirty-six healthy subjects completed a randomized, double-blind, placebo-controlled 4-week study. The administration group took 50 mg Vigiis® 101-LAB /one capsule/day (= 5 billion NTU 101 CFU/day) for four weeks. After just one week of administration, the bacterial counts of Bifidobacterium spp. and Lactobacillus spp. in the feces of the treatment group were significantly higher than the placebo group. After four weeks, the treatment group’s bacterial counts of Bifidobacterium spp. and Lactobacillus spp. were 4.01-fold and 4.25-fold higher than the placebo group. These results indicate that supplementation of Vigiis® 101-LAB significantly increases good bacteria in the gut in just one week and maintains those elevated counts for four weeks. People can benefit from compelling effects of Vigiis® 101-LAB, efficacious and science-supported probiotic. John Pan, President of SunWay Biotech, commented that “It is important to maintain a healthy microbial balance in the gut microbiome with quality and clinically proven ingredients.” For more information, please get in touch with us: globalservice@sunway.cc Reference: Effects of Vigiis 101-LAB on a healthy population’s gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study. (link) […]
- Author: sunway
- Category: Company News